8-member panel formed in Jan was tasked to review regulatory purview of nutraceuticals on account of overlapping issues of nutraceuticals with drugs. It gave report to govt this month.
Mefenamic acid, sold under various brand names such as Meftal, Mefanorm, and Mefkind, can cause DRESS Syndrome, a rare but serious condition that can damage the liver, heart, and lungs.
Provision included in draft bill to be approved by Union cabinet. Existing drugs law mentions product recall, but doesn't specify timelines or system for auditing and accountability.
The concern is not that 2025’s rally was irrational, but that it may be difficult to repeat. Outlooks remain anchored to AI investment and growth without reigniting inflation.
If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.
Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.
COMMENTS